Cancer nanomedicine: progress, challenges and opportunities.
about
Theranostic Probes for Targeting Tumor Microenvironment: An Overview.Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection.Dual-targeted peptide-conjugated multifunctional fluorescent probe with AIEgen for efficient nucleus-specific imaging and long-term tracing of cancer cellsOptofluidic device for the quantification of circulating tumor cells in breast cancer.Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo.The impact of receptor recycling on the exocytosis of αvβ3 integrin targeted gold nanoparticles.Nuclear Membrane-Targeted Gold Nanoparticles Inhibit Cancer Cell Migration and InvasionEnhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.Cellular uptake of nanoparticles: journey inside the cell.Degradable Vanadium Disulfide Nanostructures with Unique Optical and Magnetic Functions for Cancer Theranostics.Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis.Multifunctional nanodiamonds in regenerative medicine: Recent advances and future directions.Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Yeast capsules for targeted delivery: the future of nanotherapy?Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Nanomedicine Strategies to Target Tumor-Associated Macrophages.Nanomaterial-Enabled Cancer Therapy.Cationic Nanohydrogel Particles for Therapeutic Oligonucleotide Delivery.Covalent nano delivery systems for selective imaging and treatment of brain tumors.Imaging of anticancer drug action in single cells.Cyclodextrin-based biological stimuli-responsive carriers for smart and precision medicine.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Tumor Microenvironment on a Chip: The Progress and Future Perspective.A pH responsive complexation-based drug delivery system for oxaliplatinMithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.Systemic toxicity induced by aggregated layered double hydroxide nanoparticles.Rethinking cancer nanotheranostics.Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ.ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.X-Ray responsive nanoparticles with triggered release of nitrite, a precursor of reactive nitrogen species, for enhanced cancer radiosensitization.The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency.Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems.Targeting and isolation of cancer cells using micro/nanomotors.Lessons from immuno-oncology: a new era for cancer nanomedicine?Exerting Enhanced Permeability and Retention Effect Driven Delivery by Ultrafine Iron Oxide Nanoparticles with T1-T2 Switchable Magnetic Resonance Imaging Contrast.The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines.Integration of IR-808 Sensitized Upconversion Nanostructure and MoS2 Nanosheet for 808 nm NIR Light Triggered Phototherapy and Bioimaging.
P2860
Q30354655-B99B2408-47C8-477B-B7A2-20292BDD7FAEQ30363234-2C421527-769F-4391-8B47-BE38FA584D27Q33800277-44E54D16-2848-441D-8F4D-82365268D1F5Q33808137-09E83B83-DE72-4960-85B3-17795262C668Q33821050-9AEEB9B0-7908-42EC-8C51-CAAE98E3CB3DQ33888896-D9A86E95-ACD0-4A57-81D8-BA729B0E6B74Q36319488-70E1328C-8AA1-4040-A765-2F82B0114BB9Q37735811-8B130C1F-3756-41B7-A083-54423B9C7E96Q38557482-1C492FE3-AF48-4B7A-9F8D-1BE1DADF605FQ38620810-207B933F-72AE-4150-9F5B-60306819C6EEQ38632042-F6CFCAFD-5B02-4A15-9979-D7DAFDE2029EQ38673088-A3AF2E7D-87B3-4D82-B181-3979A9C1BCB5Q38674654-355A5D67-D629-4D4A-A788-91A5FC5F47FCQ38676164-965374CD-B2E1-4EF4-A5C0-AAAEE2E668EFQ38691189-B288081B-ADAD-447F-8545-FFDAB5677808Q38695683-70237EB3-9E96-4AE1-97C0-B8F3BBF1DB41Q39216032-C8A111B5-42CB-433A-B8D3-4470E451AE37Q39283111-CEEDC6CB-E91E-4184-8B6E-D3C0EFCD2CE0Q39323096-141A728C-97D6-48CB-9DD7-29AB382C63F2Q39366778-676DD215-953E-4CE4-9DBE-A15177153364Q39367664-5DF1B077-CEA4-42C8-87F0-6FFA52EB252FQ39392711-FC04303A-4E77-458E-8533-D92B17F33CFBQ39447331-A397F795-9AC6-444B-98E9-56FCB6C58002Q40044791-5B8AD06D-14A8-4128-B547-264F1131C2CBQ41670199-097ABC71-413C-486B-93F1-3B49205FDED8Q41912667-B8C1D15E-21D7-45BC-8259-B44CCDCE2933Q42284455-84377A43-337E-4813-ACEA-7F85E36BD47DQ42373129-E63821CF-558D-41E6-8E2B-19E290D31503Q42640884-0004B87E-94ED-42E0-888F-0F88E503406DQ42658857-C72CAA6C-FB76-437A-809B-B6911D9D5DCBQ43264652-6E3F4CB0-D541-45A9-8980-486DC3DF0734Q43422104-F573E6D3-E3B4-427E-9E63-35D4197BE7AAQ44395334-ED63EC1E-BE6C-4079-81C3-F495B44C5876Q45338727-9FD6F107-AB42-4AC9-A0C5-CE19C501DB79Q45816852-BAFE47C8-1EB2-4B03-A36C-114B8F58B138Q45983589-9F5B2F09-7739-4E78-AE4D-41D1ED533DEFQ46085540-55A596BC-AB36-4378-AF5D-FF263BE3D031Q46196428-124F4622-6A73-4D96-9BC7-31CC1A1D3A33Q46252865-08D2EB71-237C-4601-8A88-6B8590CE96E7Q46331790-22544849-C04C-43DD-A914-752CAED8FC5D
P2860
Cancer nanomedicine: progress, challenges and opportunities.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cancer nanomedicine: progress, challenges and opportunities.
@en
Cancer nanomedicine: progress, challenges and opportunities.
@nl
type
label
Cancer nanomedicine: progress, challenges and opportunities.
@en
Cancer nanomedicine: progress, challenges and opportunities.
@nl
prefLabel
Cancer nanomedicine: progress, challenges and opportunities.
@en
Cancer nanomedicine: progress, challenges and opportunities.
@nl
P2093
P2860
P356
P1476
Cancer nanomedicine: progress, challenges and opportunities.
@en
P2093
Jinjun Shi
Omid C Farokhzad
Richard Wooster
P2860
P2888
P356
10.1038/NRC.2016.108
P407
P577
2016-11-11T00:00:00Z